PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.\', \'Department of Clinical Engineering and Information Technology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.\', \'State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China. diaohy@zju.edu.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41419-021-04012-z
?:doi
?:hasPublicationType
?:journal
  • Cell death & disease
is ?:pmid of
?:pmid
?:pmid
  • 34301919
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • RBM15-mediated N6-methyladenosine modification affects COVID-19 severity by regulating the expression of multitarget genes.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all